Iloperidone Patent Expiration
Iloperidone is Used for the acute treatment of adults with schizophrenia. It was first introduced by Vanda Pharmaceuticals Inc
Iloperidone Patents
Given below is the list of patents protecting Iloperidone, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Fanapt | US9074254 | Method of predicting a predisposition to QT prolongation | Dec 28, 2031 | Vanda Pharms Inc |
| Fanapt | US9074256 | Method of predicting a predisposition to QT prolongation | Feb 10, 2031 | Vanda Pharms Inc |
| Fanapt | US9072742 | Method of predicting a predisposition to QT prolongation | Jan 16, 2031 | Vanda Pharms Inc |
| Fanapt | US9074255 | Method of predicting a predisposition to QT prolongation | Dec 17, 2030 | Vanda Pharms Inc |
| Fanapt | US8999638 | Method of treatment based on polymorphisms of the KCNQ1 gene | Oct 28, 2030 | Vanda Pharms Inc |
| Fanapt | US8652776 | Prediction of QT prolongation based on SNP genotype | Aug 31, 2030 | Vanda Pharms Inc |
| Fanapt | US9157121 | Method of treatment based on polymorphisms of the KCNQ1 gene | Apr 05, 2030 | Vanda Pharms Inc |
| Fanapt | US8586610 | Methods for the administration of iloperidone | Nov 02, 2027 | Vanda Pharms Inc |
| Fanapt | US9138432 | Methods for the administration of iloperidone | Sep 30, 2025 | Vanda Pharms Inc |
| Fanapt | USRE39198 | Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgesics |
Nov 15, 2016
(Expired) | Vanda Pharms Inc |
Iloperidone's Family Patents
Explore Our Curated Drug Screens
Iloperidone Generic API Manufacturers
Several generic applications have been filed for Iloperidone. The first generic version for Iloperidone was by Inventia Healthcare Ltd and was approved on Nov 28, 2016. And the latest generic version is by Lupin Ltd and was approved on May 5, 2022.
Given below is the list of companies who have filed for Iloperidone generic, along with the locations of their manufacturing plants worldwide.
1. INVENTIA
Inventia Healthcare Ltd has filed for 7 different strengths of generic version for Iloperidone. Given below are the details of the strengths of this generic introduced by Inventia.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 12MG | tablet | Discontinued | ORAL | N/A | Nov 28, 2016 |
| 1MG | tablet | Discontinued | ORAL | N/A | Nov 28, 2016 |
| 2MG | tablet | Discontinued | ORAL | N/A | Nov 28, 2016 |
| 4MG | tablet | Discontinued | ORAL | N/A | Nov 28, 2016 |
| 6MG | tablet | Discontinued | ORAL | N/A | Nov 28, 2016 |
| 8MG | tablet | Discontinued | ORAL | N/A | Nov 28, 2016 |
| 10MG | tablet | Discontinued | ORAL | N/A | Nov 28, 2016 |
Manufacturing Plant Locations New
Inventia's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Inventia as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| India |
| |||||
2. LUPIN LTD
Lupin Ltd has filed for 7 different strengths of generic version for Iloperidone. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1MG | tablet | Discontinued | ORAL | N/A | May 5, 2022 |
| 2MG | tablet | Discontinued | ORAL | N/A | May 5, 2022 |
| 4MG | tablet | Discontinued | ORAL | N/A | May 5, 2022 |
| 6MG | tablet | Discontinued | ORAL | N/A | May 5, 2022 |
| 8MG | tablet | Discontinued | ORAL | N/A | May 5, 2022 |
| 10MG | tablet | Discontinued | ORAL | N/A | May 5, 2022 |
| 12MG | tablet | Discontinued | ORAL | N/A | May 5, 2022 |
Manufacturing Plant Locations New
Lupin Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Lupin Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
3. TARO
Taro Pharmaceutical Industries Ltd has filed for 7 different strengths of generic version for Iloperidone. Given below are the details of the strengths of this generic introduced by Taro.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1MG | tablet | Discontinued | ORAL | N/A | Jul 22, 2019 |
| 2MG | tablet | Discontinued | ORAL | N/A | Jul 22, 2019 |
| 4MG | tablet | Discontinued | ORAL | N/A | Jul 22, 2019 |
| 6MG | tablet | Discontinued | ORAL | N/A | Jul 22, 2019 |
| 8MG | tablet | Discontinued | ORAL | N/A | Jul 22, 2019 |
| 10MG | tablet | Discontinued | ORAL | N/A | Jul 22, 2019 |
| 12MG | tablet | Discontinued | ORAL | N/A | Jul 22, 2019 |
Manufacturing Plant Locations New
Taro's manufacturing plants are situated in 3 countries - United States, Israel, Canada. Given below are the details of these plant locations as well as the firm names of Taro as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
| Israel |
| |||||
| Canada |
| |||||